查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084915

輔助生殖技術市場：依產品、手術類型、週期類型、不孕症類型和最終用戶分類－2026-2032年全球市場預測

Assisted Reproductive Technology Market by Product, Procedure Type, Cycle Type, Infertility Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，輔助生殖技術市場將成長至 1,115.1 億美元，複合年成長率為 18.11%。

主要市場統計數據
基準年 2025 347.6億美元
預計年份：2026年 409.4億美元
預測年份 2032 1115.1億美元
複合年成長率 (%) 18.11%

輔助生殖技術（ART）正從不孕症的專門治療手段轉變為生殖醫學的核心組成部分。體外受精（IVF）、卵胞漿內單一精子注射（ICSI）、胚胎胚胎著床前遺傳學檢測（PGD）、冷凍保存、捐精服務以及針對癌症相關疾病和特定適應症的生殖功能保存等技術為該行業的發展提供了支持。

需求得到了基於證據的人口統計和臨床趨勢的支持。世界衛生組織（WHO）估計，大約六分之一的成年人在一生中的某個階段會經歷不孕不育。同時，美國疾病管制與預防中心（CDC）和輔助生殖技術協會（SART）的國家登記資料顯示，輔助生殖技術（ART）促成的出生占美國所有出生嬰兒的2%以上。生育年齡的延遲、不孕症診斷率的提高、胚胎培養系統的改進以及保險公司和雇主提供的生育福利的擴大，正在重塑治療途徑、患者期望以及市場競爭格局。

藝術領域的變革性變化

輔助生殖技術（ART）領域正經歷著變革，以患者為中心的護理模式、檢查室數位化以及生育力保存方法的擴展正在推動這一變革。診所透過結合體外受精（IVF）、卵胞漿胚胎著床前遺傳學檢測（PGT）、玻璃化冷凍和冷凍保存、遺傳諮詢以及遠距遠端醫療的連續性、透明度和臨床協作水平。

人工智慧對藝術治療的累積影響

人工智慧 (AI) 正透過胚胎影像評估、精子選擇輔助、工作流程自動化、卵巢刺激決策支援以及週期管理預測分析等方式，開始影響輔助生殖技術 (ART)。這些工具在減少變異性、增強記錄保存、支持檢查室一致性以及幫助胚胎學家利用標準化和可審計的數據來確定胚胎優先級方面具有重要價值。

ART市場關鍵區域洞察

亞太地區是輔助生殖技術（ART）蓬勃發展的地區，這得益於其龐大的育齡人口、日益成長的不孕不育意識、醫療旅遊的興起，以及印度、中國、日本、韓國、泰國、新加坡和澳大利亞等國不斷擴展的診所網路。中國和印度憑藉著都市化和私人生育治療的普及，擁有龐大的規模；而日本和韓國則受到低出生率和政府對家庭建設的重視的影響。澳洲仍然是一個監管良好的市場，擁有先進的生育服務和臨床標準，並有完善的註冊系統作為保障。

基於群體的全球輔助生殖技術需求關鍵洞察

東協逐漸成為生育治療的重要中心，但泰國、馬來西亞、新加坡、越南、印尼和菲律賓等國的診所成熟度、成本效益和法律規範水平各不相同。新加坡注重高品質的專科護理和嚴格的醫療標準，而泰國和馬來西亞則受益於區域醫療旅遊、具有競爭力的私立生育服務以及患者意識的不斷提高。

影響抗愛滋病毒療法傳播的主要國家趨勢

美國在輔助生殖技術（ART）創新、私人診所整合、雇主提供的福利以及胚胎胚胎著床前遺傳學檢測（PGT）和卵子冷凍技術的廣泛主導處於領先地位。根據美國疾病管制與預防中心（CDC）的數據顯示，ART佔全美所有新生兒的2%以上。在加拿大，部分省份的公共資金投入和私人診所的成長共同推動了該領域的發展。墨西哥則吸引著尋求經濟實惠且靈活的治療途徑的跨境患者。巴西擁有專業的診所、醫療機構以及日益成長的生育治療意識，是拉丁美洲最大的ART中心。

為藝術產業領導者提供的實用建議

行業領導者應優先考慮可衡量的療效、倫理透明度和成本效益。診所和技術提供者可以透過發布檢驗的成功指標、提高週期性數據品質以及透過資金籌措、諮詢、基因教育和清晰的治療路徑來支持患者，從而鞏固其市場地位。

輔助生殖技術市場分析的調查方法

本執行摘要是基於對經認證的公共衛生機構、不孕症登記處、臨床學會出版刊物、監管資訊來源、人口統計資料庫和公開的醫療保健系統資訊的三角化二次檢驗。主要參考文獻包括世界衛生組織不孕症估計數據、美國疾病管制與預防中心和美國輔助生殖技術協會的輔助生殖技術監測數據、歐洲人類生殖與胚胎學會的登記操作數據、人類受精與胚胎管理局的報告以及國家生殖醫學指南。

關於輔助生殖科技未來的結論

不孕症上升、生育年齡延遲、生育力保存需求以及人口壓力等因素共同決定了輔助生殖技術（ART）的重要性將持續存在。能夠將卓越的臨床技術與透明的治療結果、數位互動、負責任地使用人工智慧、規範的冷凍保存以及完善的跨境服務模式相結合的醫療服務提供商，將擁有最大的商業機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：輔助生殖科技市場：依產品分類

  • 消耗品
  • 裝置
  • 培養基和試劑

第8章：輔助生殖科技市場：依手術類型分類

  • 輸卵管內配子移植
  • 體外受精
    • 新鮮捐贈者
    • 新鮮非捐贈者
    • 冷凍
  • 胞漿內單一精子注射
  • 子宮內人工授精
  • 受精卵輸卵管內移植

第9章：輔助生殖科技市場：依週期類型分類

  • 新鮮捐贈者
  • 新鮮胚胎，非捐贈者
  • 冷凍

第10章：輔助生殖科技市場：依不孕症類型分類

  • 女性不孕症
    • 排卵障礙
    • 輸卵管阻塞
    • 子宮內膜異位症
  • 男性不孕
    • 精子數量減少
    • 動力減弱
    • 無精子症
  • 不明原因不孕
  • 與老齡化相關的不孕症

第11章：輔助生殖科技市場：依最終使用者分類

  • 門診手術中心
  • 不孕症治療診所
  • 醫院

第12章：輔助生殖科技市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：輔助生殖科技市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：輔助生殖科技市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • BioIVT, LLC
  • BioLife Solutions, Inc.
  • Carl Zeiss AG
  • CIVCO Medical Solutions
  • Cook Medical LLC
  • CooperSurgical Inc
  • Corning Incorporated
  • CryoLogix LLC
  • Cryoport, Inc.
  • Eppendorf AG
  • Esco Lifesciences Group Ltd
  • Ferring Pharmaceuticals A/S
  • FUJIFILM Irvine Scientific Sales Company, Inc.
  • Genea Biomedx Pty Ltd
  • Hamilton Thorne Ltd.
  • Hunter Scientific Ltd.
  • IMV Technologies
  • IVF Express
  • IVFsynergy Ltd
  • Kitazato Corporation
  • Labotect GmbH
  • Memmert GmbH+Co. KG
  • Merck KGaA
  • Nidacon International AB
  • Olympus Corporation
  • Progyny, Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific Inc.
  • TMRW Life Sciences, Inc.
  • Vitrolife AB
Product Code: MRR-436901065A94

The Assisted Reproductive Technology Market is projected to grow by USD 111.51 billion at a CAGR of 18.11% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 34.76 billion
Estimated Year [2026] USD 40.94 billion
Forecast Year [2032] USD 111.51 billion
CAGR (%) 18.11%

Assisted reproductive technology is moving from a specialized infertility intervention to a core component of reproductive health care. The industry is anchored by in vitro fertilization, intracytoplasmic sperm injection, preimplantation genetic testing, cryopreservation, donor services, and fertility preservation for oncology-related and elective indications.

Demand is supported by verified demographic and clinical trends. The World Health Organization estimates that about one in six adults experience infertility during their lifetime, while national registries such as the CDC and SART in the United States show that ART accounts for more than 2% of U.S. births. Delayed parenthood, rising infertility diagnosis, improved embryo culture systems, and broader insurance or employer-sponsored fertility benefits are reshaping access, patient expectations, and competitive positioning.

Transformative Shifts in the ART Landscape

The assisted reproductive technology landscape is being transformed by patient-centric care models, laboratory digitization, and expanding fertility preservation. Clinics are increasingly combining IVF, ICSI, PGT, vitrification, genetic counseling, and telehealth-enabled patient engagement to improve treatment continuity, transparency, and clinical coordination.

Regulation is also reshaping market behavior. Data privacy rules, embryo handling standards, donor screening requirements, tissue and cell traceability, and advertising controls are becoming more important as cross-border fertility care expands. Providers that can document live birth outcomes, laboratory quality, ethical governance, and equitable access are better positioned to gain patient, clinician, and payer confidence.

Cumulative Impact of Artificial Intelligence in ART

Artificial intelligence is beginning to influence ART through embryo image assessment, sperm selection support, workflow automation, ovarian stimulation decision support, and predictive analytics for cycle management. These tools are most valuable when they reduce variability, enhance documentation, support laboratory consistency, and help embryologists prioritize embryos using standardized, auditable data.

The cumulative impact of AI will depend on clinical validation rather than marketing claims. Regulators, clinicians, and patients increasingly expect evidence that AI systems improve decision-making without introducing bias, privacy risk, or unproven outcome promises. Industry leaders should treat AI as a quality-enhancing layer integrated with embryologist expertise, not as a replacement for clinical judgment.

Key Regional Insights for ART Markets

Asia-Pacific is a dynamic ART region due to large reproductive-age populations, rising infertility awareness, medical travel, and expanding clinic networks in India, China, Japan, South Korea, Thailand, Singapore, and Australia. China and India offer scale through urbanization and growing private fertility care, while Japan and South Korea are shaped by low fertility rates and government attention to family formation. Australia remains a well-regulated market with advanced fertility services and registry-supported clinical standards.

North America is characterized by advanced clinical infrastructure, CDC and SART reporting standards, employer fertility benefits, and strong uptake of PGT, egg freezing, and donor services. Latin America is led by Brazil and Mexico, where private clinics and cross-border affordability attract domestic and international patients. Europe remains one of the most regulated ART environments, supported by ESHRE-linked registry activity, national reimbursement differences, mature fertility clinic networks, and strict frameworks for gamete donation, embryo transfer, and patient consent.

The Middle East is gaining momentum through the UAE, Saudi Arabia, and Qatar, where private health investment and family-building priorities support premium IVF services within culturally specific regulatory frameworks. Africa remains underpenetrated, but Egypt, South Africa, Nigeria, and Kenya are expanding ART access as urban fertility centers, specialist training, reproductive health awareness, and private investment improve availability.

Key Group Insights Across Global ART Demand

ASEAN is emerging as an important fertility care corridor, with Thailand, Malaysia, Singapore, Vietnam, Indonesia, and the Philippines showing different levels of clinic maturity, affordability, and regulatory oversight. Singapore emphasizes high-quality specialty care and strict medical standards, while Thailand and Malaysia benefit from regional medical travel, competitive private fertility services, and growing patient awareness.

The GCC is shaped by high private health expenditure, expanding specialty hospitals, and strong demand for culturally compliant fertility services. The European Union emphasizes safety, traceability, data protection, and quality systems, making compliance with tissue, cell, medical device, and privacy rules central to ART operations. BRICS countries collectively represent major procedure-volume potential, particularly through China, India, and Brazil, where large populations, delayed parenthood, urban health care access, and expanding private care ecosystems support long-term ART adoption.

G7 markets lead in technology adoption, clinical research, advanced genetic testing, fertility preservation, and registry-based reporting, though reimbursement and patient access vary widely. NATO countries are not a fertility-specific bloc, but many member states overlap with advanced North American and European ART markets where supply chain resilience, cybersecurity, health data governance, and continuity of cryostorage operations increasingly influence clinical decision-making.

Key Country Insights Shaping ART Adoption

The United States leads in ART innovation, private clinic consolidation, employer benefits, and adoption of PGT and egg freezing, with CDC reporting that ART contributes more than 2% of national births. Canada combines public funding in selected provinces with private clinic growth, while Mexico attracts cross-border patients seeking affordability and flexible treatment access. Brazil is Latin America's largest ART center of activity, supported by specialist clinics, medical societies, and rising fertility awareness.

In Europe, the United Kingdom is guided by HFEA oversight and transparent clinic reporting, Germany and France operate within structured reimbursement and regulatory systems, Italy and Spain remain important IVF destinations, and Spain is especially recognized for donor egg treatment under established reproductive medicine regulation. Russia has historically been a sizable ART market, although geopolitical, payment, and international travel risks affect cross-border participation.

China and India represent high-volume opportunity due to population scale, urbanization, delayed marriage, infertility awareness, and expanding fertility clinic networks. Japan and South Korea face demographic urgency from low birth rates, supporting policy attention to fertility services, financial assistance, and fertility preservation. Australia has a mature ART ecosystem with strong clinical standards and registry participation, while South Korea combines advanced health technology with growing public concern over fertility decline.

Actionable Recommendations for ART Industry Leaders

Industry leaders should prioritize measurable outcomes, ethical transparency, and patient affordability. Clinics and technology providers can strengthen market position by publishing validated success metrics, improving cycle-level data quality, and supporting patients with financing, counseling, genetic education, and clear treatment pathways.

Strategic investment should focus on laboratory standardization, embryology workforce development, AI governance, cryostorage risk management, secure digital patient platforms, and compliance-ready documentation. Expansion plans should be tailored to local reimbursement, donor rules, embryo regulations, data protection requirements, and cultural expectations rather than relying on a uniform global model.

Research Methodology for ART Market Intelligence

This executive summary is based on triangulated secondary research from recognized public health agencies, fertility registries, clinical society publications, regulatory sources, demographic databases, and publicly available health system information. Key reference points include WHO infertility estimates, CDC and SART ART surveillance, ESHRE registry work, HFEA reporting, and national reproductive medicine guidelines.

The methodology evaluates demand drivers, procedure adoption, technology trends, reimbursement structures, regional regulations, competitive behavior, and patient access dynamics. Insights are validated through cross-comparison of registry data, peer-reviewed clinical evidence, regulatory signals, demographic indicators, and market activity to ensure fact-based interpretation without using market sizing, share, or forecasting assumptions.

Conclusion on the Future of Assisted Reproductive Technology

Assisted reproductive technology is set for sustained relevance as infertility prevalence, delayed parenthood, fertility preservation, and demographic pressures converge. The strongest opportunities will come from providers that combine clinical excellence with transparent outcomes, digital engagement, responsible AI, compliant cryostorage, and well-governed cross-border service models.

Future industry leadership will depend on trust. Organizations that align innovation with evidence, patient safety, ethical governance, regulatory compliance, and affordability will be best positioned to serve patients across mature and emerging ART markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Assisted Reproductive Technology Market, by Product

  • 7.1. Consumables
  • 7.2. Equipment
  • 7.3. Media And Reagents

8. Assisted Reproductive Technology Market, by Procedure Type

  • 8.1. Gamete Intrafallopian Transfer
  • 8.2. In Vitro Fertilization
    • 8.2.1. Fresh Donor
    • 8.2.2. Fresh Non-Donor
    • 8.2.3. Frozen
  • 8.3. Intracytoplasmic Sperm Injection
  • 8.4. Intrauterine Insemination
  • 8.5. Zygote Intrafallopian Transfer

9. Assisted Reproductive Technology Market, by Cycle Type

  • 9.1. Fresh Donor
  • 9.2. Fresh Non-Donor
  • 9.3. Frozen

10. Assisted Reproductive Technology Market, by Infertility Type

  • 10.1. Female Infertility
    • 10.1.1. Ovulation disorders
    • 10.1.2. Tubal blockage
    • 10.1.3. Endometriosis
  • 10.2. Male Infertility
    • 10.2.1. Low sperm count
    • 10.2.2. Poor motility
    • 10.2.3. Azoospermia
  • 10.3. Unexplained Infertility
  • 10.4. Age-related Infertility

11. Assisted Reproductive Technology Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Fertility Clinics
  • 11.3. Hospitals

12. Assisted Reproductive Technology Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Assisted Reproductive Technology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Assisted Reproductive Technology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. BioIVT, LLC
  • 16.2. BioLife Solutions, Inc.
  • 16.3. Carl Zeiss AG
  • 16.4. CIVCO Medical Solutions
  • 16.5. Cook Medical LLC
  • 16.6. CooperSurgical Inc
  • 16.7. Corning Incorporated
  • 16.8. CryoLogix LLC
  • 16.9. Cryoport, Inc.
  • 16.10. Eppendorf AG
  • 16.11. Esco Lifesciences Group Ltd
  • 16.12. Ferring Pharmaceuticals A/S
  • 16.13. FUJIFILM Irvine Scientific Sales Company, Inc.
  • 16.14. Genea Biomedx Pty Ltd
  • 16.15. Hamilton Thorne Ltd.
  • 16.16. Hunter Scientific Ltd.
  • 16.17. IMV Technologies
  • 16.18. IVF Express
  • 16.19. IVFsynergy Ltd
  • 16.20. Kitazato Corporation
  • 16.21. Labotect GmbH
  • 16.22. Memmert GmbH + Co. KG
  • 16.23. Merck KGaA
  • 16.24. Nidacon International AB
  • 16.25. Olympus Corporation
  • 16.26. Progyny, Inc.
  • 16.27. The Cooper Companies, Inc.
  • 16.28. Thermo Fisher Scientific Inc.
  • 16.29. TMRW Life Sciences, Inc.
  • 16.30. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FRESH DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FRESH DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FRESH DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FRESH NON-DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FRESH NON-DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FRESH NON-DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FROZEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FRESH DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FRESH DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FRESH DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FRESH NON-DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FRESH NON-DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FRESH NON-DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FROZEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OVULATION DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OVULATION DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OVULATION DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TUBAL BLOCKAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TUBAL BLOCKAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TUBAL BLOCKAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LOW SPERM COUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LOW SPERM COUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LOW SPERM COUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POOR MOTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POOR MOTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POOR MOTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGE-RELATED INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AGE-RELATED INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGE-RELATED INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 188. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 210. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 212. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 216. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 219. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 246. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 264. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 269. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 270. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 273. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 275. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 278. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 279. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 282. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 284. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 287. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 288. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 300. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 302. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 305. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 306. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 309. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 311. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 314. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 315. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 318. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 320. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 323. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 324. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 327. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. S